Table 3.
Parameters 1 | Group | Between-Group 2 | |
---|---|---|---|
Control | Treatment | ||
Weight (kg) | |||
Baseline | 91.95 ± 11.42 | 91.98 ± 9.96 | |
28 Days | 91.03 ± 11.47 | 91.26 ± 9.53 | |
Change | −0.010 ± 0.017 | −0.007 ± 0.021 | 0.43 |
Within-Group 3 | 0.30 | 0.26 | |
BMI (kg/m2) | |||
Baseline | 32.31 ± 4.14 | 32.07 ± 4.25 | |
28 Days | 31.93 ± 4.35 | 31.95 ± 4.28 | |
Change | −0.012 ± 0.019 | −0.003 ± 0.030 | 0.17 |
Within-Group 3 | 0.42 | 0.57 | |
Neck Circumference (cm) | |||
Baseline | 42.36 ± 11.17 | 39.61 ± 8.05 | |
28 Days | 39.78 ± 3.54 | 39.27 ± 8.04 | |
Change | −0.035 ± 0.110 | −0.044 ± 0.182 | 0.19 |
Within-Group 3 | 0.07 | 0.15 | |
Waist circumference (cm) | |||
Baseline | 108.60 ± 12.83 | 108.32 ± 12.72 | |
28 Days | 107.57 ± 12.51 | 107.32 ± 12.13 | |
Change | −0.009 ± 0.015 | −0.009 ± 0.018 | 0.91 |
Within-Group 3 | 0.45 | 0.05 | |
Hip circumference (cm) | |||
Baseline | 112.88 ± 10.02 | 109.77 ± 23.88 | |
28 Days | 112.19 ± 9.85 | 111.86 ± 11.30 | |
Change | −0.006 ± 0.014 | −0.010 ± 0.023 | 0.68 |
Within-Group 3 | 0.04 | 0.04 | |
Whole Body phA° | |||
Baseline | 6.43 ± 0.66 | 6.11 ± 1.76 | |
28 Days | 6.48 ± 0.75 | 6.32 ± 1.39 | |
Change | 0.009 ± 0.060 | 0.004 ± 0.069 | 0.56 |
Within-Group 3 | 0.56 | 0.85 | |
FFM (kg) | |||
Baseline | 62.45 ± 9.50 | 58.40 ± 17.89 | |
28 Days | 62.38 ± 10.08 | 61.19 ± 15.53 | |
Change | −0.002 ± 0.042 | 0.013 ± 0.053 | 0.49 |
Within-Group 3 | 0.14 | 0.58 | |
FM (kg) | |||
Baseline | 30.49 ± 10.34 | 29.59 ± 15.94 | |
28 Days | 29.37 ± 10.80 | 28.99 ± 13.36 | |
Change | −0.041 ± 0.116 | −0.032 ± 0.097 | 0.97 |
Within-Group 3 | 0.14 | 0.14 |
1 As mean and standard deviation for continuous variables and as frequency and percentage (%) for categorical. 2 Wilcoxon rank-sum test (Mann–Whitney); 3 Wilcoxon matched-pairs signed-rank test. Abbreviations: BMI, body mass index; Rz, resistance; XC, reactance; phA, phase angle; BCM, body cell mass; FFM, free fat mass; FM, fat mass.